Literature DB >> 28375596

Efficient Transcriptional Gene Repression by Type V-A CRISPR-Cpf1 from Eubacterium eligens.

Seong Keun Kim1,2, Haseong Kim1,2, Woo-Chan Ahn3, Kwang-Hyun Park3, Eui-Jeon Woo3,4, Dae-Hee Lee1,2, Seung-Goo Lee1,2.   

Abstract

Clustered regularly interspaced short palindromic repeats interference (CRISPRi) is an emerging technology for artificial gene regulation. Type II CRISPR-Cas endonuclease Cas9 is the most widely used protein for gene regulation with CRISPRi. Here, we present type V-A CRISPR-Cas endonuclease Cpf1-based CRISPRi. We constructed an l-rhamnose-inducible CRISPRi system with DNase-deactivated Cpf1 from Eubacterium eligens (EedCpf1) and compared its performance with catalytically deactivated Cas9 from Streptococcus pyogenes (SpdCas9). In contrast to SpdCas9, EedCpf1 showed stronger gene repression when it was targeted to the template strand than when it was targeted to the nontemplate strand of the 5' untranslated region or coding DNA sequences. EedCpf1 exhibited no strand bias when targeted to the promoter, and preferentially used the 5'-TTTV-3' (V = A, G, or C) protospacer adjacent motif. Multiplex repression of the EedCpf1-based CRISPRi system was demonstrated using episomal and chromosomal gene targets. Our findings will guide an efficient EedCpf1-mediated CRISPRi genetic control.

Entities:  

Keywords:  CRISPRi; Eubacterium eligens; Streptococcus pyogenes; deactivated Cas9; deactivated Cpf1; protospacer adjacent motif

Mesh:

Substances:

Year:  2017        PMID: 28375596     DOI: 10.1021/acssynbio.6b00368

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  27 in total

Review 1.  CRISPR Tools To Control Gene Expression in Bacteria.

Authors:  Antoine Vigouroux; David Bikard
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-01       Impact factor: 11.056

Review 2.  Class 2 CRISPR-Cas RNA-guided endonucleases: Swiss Army knives of genome editing.

Authors:  Stefano Stella; Pablo Alcón; Guillermo Montoya
Journal:  Nat Struct Mol Biol       Date:  2017-10-16       Impact factor: 15.369

Review 3.  The Conspicuity of CRISPR-Cpf1 System as a Significant Breakthrough in Genome Editing.

Authors:  Hadi Bayat; Mohammad Hossein Modarressi; Azam Rahimpour
Journal:  Curr Microbiol       Date:  2017-11-30       Impact factor: 2.188

4.  Massively parallel CRISPRi assays reveal concealed thermodynamic determinants of dCas12a binding.

Authors:  David A Specht; Yasu Xu; Guillaume Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-06       Impact factor: 11.205

5.  CRISPR-Cpf1-Assisted Multiplex Genome Editing and Transcriptional Repression in Streptomyces.

Authors:  Lei Li; Keke Wei; Guosong Zheng; Xiaocao Liu; Shaoxin Chen; Weihong Jiang; Yinhua Lu
Journal:  Appl Environ Microbiol       Date:  2018-08-31       Impact factor: 4.792

6.  CRISPR Interference as a Tool to Repress Gene Expression in Haloferax volcanii.

Authors:  Thandi S Schwarz; Sandra S Schreiber; Anita Marchfelder
Journal:  Methods Mol Biol       Date:  2022

Review 7.  CRISPR-Based Approaches for Gene Regulation in Non-Model Bacteria.

Authors:  Stephanie N Call; Lauren B Andrews
Journal:  Front Genome Ed       Date:  2022-06-23

8.  Computational pipeline for designing guide RNAs for mismatch-CRISPRi.

Authors:  Jordi van Gestel; John S Hawkins; Horia Todor; Carol A Gross
Journal:  STAR Protoc       Date:  2021-05-05

9.  Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome.

Authors:  Wen-Bing Jin; Ting-Ting Li; Da Huo; Sophia Qu; Xin V Li; Mohammad Arifuzzaman; Svetlana F Lima; Hui-Qing Shi; Aolin Wang; Gregory G Putzel; Randy S Longman; David Artis; Chun-Jun Guo
Journal:  Cell       Date:  2022-01-19       Impact factor: 41.582

Review 10.  Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.

Authors:  Mariana Brütt Pacheco; Vânia Camilo; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2021-06-15       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.